Toxoplasma gondii Cyclic GMP-Dependent Kinase: Chemotherapeutic Targeting of an Essential Parasite Protein Kinase
- 1 June 2002
- journal article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 1 (3), 317-28
- https://doi.org/10.1128/ec.1.3.317-328.2002
Abstract
The trisubstituted pyrrole 4-[2-(4-fluorophenyl)-5-(1-methylpiperidine-4-yl)-1H-pyrrol-3-yl]pyridine (compound 1) has in vivo activity against the apicomplexan parasites Toxoplasma gondii and Eimeria tenella in animal models. The presumptive molecular target of this compound in E. tenella is cyclic GMP-dependent protein kinase (PKG). Native PKG purified from T. gondii has kinetic and pharmacologic properties similar to those of the E. tenella homologue, and both have been functionally expressed as recombinant proteins in T. gondii . Computer modeling of parasite PKG was used to predict catalytic site amino acid residues that interact with compound 1. The recombinant laboratory-generated mutants T. gondii PKG T761Q or T761M and the analogous E. tenella T770 alleles have reduced binding affinity for, and are not inhibited by, compound 1. By all other criteria, PKG with this class of catalytic site substitution is indistinguishable from wild-type enzyme. A genetic disruption of T. gondii PKG can only be achieved if a complementing copy of PKG is provided in trans , arguing that PKG is an essential protein. Strains of T. gondii , disrupted at the genomic PKG locus and dependent upon the T. gondii T761-substituted PKGs, are as virulent as wild type in mice. However, unlike mice infected with wild-type T. gondii that are cured by compound 1, mice infected with the laboratory-generated strains of T. gondii do not respond to treatment. We conclude that PKG represents the primary molecular target responsible for the antiparasitic efficacy of compound 1.Keywords
This publication has 41 references indexed in Scilit:
- Molecular Basis for p38 Protein Kinase Inhibitor SpecificityBiochemistry, 1998
- Gene Replacement in Toxoplasma gondii with Chloramphenicol Acetyltransferase as Selectable MarkerScience, 1993
- Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1993
- Transient Transfection and Expression in the Obligate Intracellular Parasite Toxoplasma gondiiScience, 1993
- Toxoplasmic Encephalitis in AIDSClinical Infectious Diseases, 1992
- Accurate modeling of protein conformation by automatic segment matchingJournal of Molecular Biology, 1992
- Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein KinaseScience, 1991
- Protein measurement using bicinchoninic acid: elimination of interfering substancesAnalytical Biochemistry, 1989
- Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndromeAmerican Journal Of Medicine, 1988
- Assessment of therapy for toxoplasma encephalitisAmerican Journal Of Medicine, 1987